McKenna Mark C.

Track

Insider profile

Performance

Overall performance
0.6
Performance over holding periods
0.6
30 days 90 days 120 days
Average return -17% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
McKenna Mark C.'s trades of Apogee Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-16 2024-12-12
B Purchase
96,821 +48.2%
354.11
US$3,267,645 		96,821 +48.2% 354.11 US$3,267,645
2024-12-16 2024-12-12
B Purchase
53,923 -29.1%
22.93
US$1,815,573 		53,923 -29.1% 22.93 US$1,815,573
2023-03-17 2023-03-15
PlS Planned sale
70,833 -36.4%
31.45
US$4,828,284 		70,833 -36.4% 31.45 US$4,828,284
2023-03-03 2023-03-03
PlS Planned sale
10,620 -16.1%
125.13
US$1,328,881 		10,620 -16.1% 125.13 US$1,328,881
2023-03-03 2023-03-01
PlS Planned sale
700 -1.3%
125.26
US$87,682 		700 -1.3% 125.26 US$87,682
2023-02-17 2023-02-17
PlS Planned sale
13,680 -19.9%
125.10
US$1,711,368 		13,680 -19.9% 125.10 US$1,711,368
2023-02-17 2023-02-16
PlS Planned sale
25,000 -31.2%
119.87
US$2,996,750 		25,000 -31.2% 119.87 US$2,996,750
2023-02-17 2023-02-15
PlS Planned sale
25,000 -31.2%
119.42
US$2,985,500 		25,000 -31.2% 119.42 US$2,985,500
2023-01-19 2023-01-17
PlS Planned sale
25,000 -31.2%
118.99
US$2,974,750 		25,000 -31.2% 118.99 US$2,974,750